Cytokinetics Inc. (cytk 3.5 07/01/27)
13F holders, Q2 2025 (June 30)3holders
0new positions
0sold out
$6.91avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Cytokinetics Inc. (cytk 3.5 07/01/27) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were Nomura Holdings Inc. ($12.5M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($1.6M) and Bank of New York Mellon Corp ($213K).
- Company
- Cytokinetics Inc. (cytk 3.5 07/01/27)
- CUSIP
- 23282WAC4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 351,531 shares sold, net −351,531 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Nomura Holdings Inc. | 0.10% | Reduce -48.1% | 379,373 | $12.5M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 1,500,000 | $1.6M |
| Bank of New York Mellon Corp | 0.00% | No change | 200,000 | $213K |
"% of holder's portfolio" is CYTOKINETICS INC (CYTK 3.5 07/01/27)'s weight in each manager's 13F, not the share of Cytokinetics Inc. (cytk 3.5 07/01/27) the manager owns.